GlycaNova is an innovative Norwegian biotechnology company focused on the modulation of the immune system using proprietary beta-glucans derived from medicinal mushrooms. Its intellectual property includes a proprietary manufacturing process, based on fermentation, to produce beta-glucans with high structural integrity and high biological activity.
GlycaNova has an exciting pipeline of beta-glucans under development for human and animal health including an adjunct therapy in cancer treatment. The Company has launched two consumer healthcare products: the nutritional supplement Lentinex for immune system support and the emollient cream Ganodex for the symptomatic treatment of psoriasis, eczema and other skin conditions.
GlycaNova is a privately owned company based in Fredrikstad, Norway.